Skip to Content
Merck
  • Continuation of ECT after recovery from transient, ECT-induced, postictal cortical blindness.

Continuation of ECT after recovery from transient, ECT-induced, postictal cortical blindness.

The journal of ECT (2011-10-11)
Sushma Sonavane, Vivek Bambole, Abha Bang, Nilesh Shah, Chittaranjan Andrade
ABSTRACT

Transient, postictal cortical blindness is a rare adverse effect of electroconvulsive therapy (ECT). There is no information on the safety of continuation of ECT in patients who recover from ECT-induced cortical blindness. An 18-year-old woman with paranoid schizophrenia experienced cortical blindness immediately after her first bifrontotemporal ECT treatment. There was complete, spontaneous recovery of vision after 6 hours. Neurological examination, computed tomography of the brain, and electroencephalographic study revealed no abnormality. A combination of circumstances suggested that continuation of ECT was desirable. After clearances from neurological and ophthalmological teams, she received 6 more ECT treatments, starting 9 days after the first. After resumption of ECT, there was marked improvement in psychopathology across the ECT course. There was no recurrence of visual symptoms. Patients who experience transient, ECT-induced, postictal cortical blindness may not necessarily experience the same adverse effect on rechallenge with ECT.

MATERIALS
Product Number
Brand
Product Description

Trihexyphenidyl hydrochloride, European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity